MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    The effect of lumboperitoneal shunt surgery on patients with iNPH plus Parkinson’s disease

    T. Tsunemi, T. Shimada, A. Sakukrai, M. Nakajima, N. Hattori (Toyoo, Japan)

    Objective: To investigate the effect of lumboperitoneal shunt surgery on patients with iNPH comorbid with Parkinson’s disease Background: Comorbid Parkinson’s disease (PD) in idiopathic normal…
  • 2023 International Congress

    Istradefylline therapy for PD plus oromandibular dystonia

    NAO. Kanzato, SAT. Mochizuki (Haearu-cho, Okinawa, Japan)

    Objective: To clarify the dopaminergic system link between parkinson's disease (PD) and oromadibular dystonias (OMDy) co-occur, and the effect of istradefylline (IST) therapy. Background: OMDy are…
  • 2023 International Congress

    Eye tracking paradigm to identify disease-specific behavioral biomarkers in neurodegeneration

    M. Habibi, B. Coe, D. Brien, H. Riek, A. Janzen, W. Oertel, D. Munoz (Marburg, Germany)

    Objective: Rapid-eye movement (REM) sleep behavior disorder (RBD) has been identified as the most specific and common prodromal stages of α-synucleinopathies (αSYN) such as Parkinson's…
  • 2023 International Congress

    Gender differences in REM Sleep Behavior Disorder in Parkinson’s disease

    EL. Ungureanu, ș. Diaconu, A. Zârnoveanu, R. Filip, M. Cușnir, B. Ciopleiaș, C. Falup-Pecurariu (Brasov, Romania)

    Objective: To study the gender differences in probable REM Sleep Behavior Disorder (RBD) and other sleep characteristics in a cohort of Parkinson’s disease (PD) patients.…
  • 2023 International Congress

    Is an integrated Parkinson’s Dementia Service the way forward?

    A. Rafeeq, C. Thomas, B. Mohamed, J. Adenwalla, S. Page, R. Lewis-Morton, S. Mahon, T. Williams (Cardiff, United Kingdom)

    Objective: To illustrate the role of a single team in managing all facets of Parkinson’s Background: The Cardiff and Vale Parkinson’s service is an integrated,…
  • 2023 International Congress

    DaT-Scans Have Limited Utility in Predicting Treatment Response to Ventriculoperitoneal Shunts in Normal Pressure Hydrocephalus

    J. Ma, M. Hamed, D. Victor, T. Kay, M. Salgado (Brooklyn, USA)

    Objective: To determine usefulness of DaT-SPECT imaging in the management of normal pressure hydrocephalus (NPH). Background: Dopamine transporter single-photon emission computed tomography (DaT-SPECT) imaging is…
  • 2023 International Congress

    Alopecia in females with young onset Parkinson’s Disease: an exploratory survey

    K. Fisher, E. Clifford, N. Piniella, A. Leder, R. Gallagher (Glen Head, USA)

    Objective: To explore the symptoms of females with young onset Parkinson's Disease (YOPD), specifically alopecia, in comparison to females with traditional onset Parkinson’s Disease (TOPD).…
  • 2023 International Congress

    The effect of continuous subcutaneous apomorphine infusion on vitamin B metabolites and plasma homocysteine in Parkinson’s disease patients

    O. Phokaewvarangkul, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the plasma level of vitamin B and homocysteine between PD patients with conventional medications and PD patients with CSAI. Background: Although levodopa…
  • 2023 International Congress

    Exploring the complementary approach of a standardized osteopathic treatment protocol on sleep quality in Parkinsons disease: A randomized controlled study

    S. Yao, J. Difrancisco-Donoghue, A. Leder, J. Mancini, J. Docherty (Old Westbury, USA)

    Objective: To investigate the complementary effects of a standardized Osteopathic Manipulative Treatment (OMT) Protocol on sleep quality using the Pittsburgh Sleep Index (PSQI) Background: Parkinson’s…
  • 2023 International Congress

    Concordant RNA patterns in Parkinson’s disease brain and peripheral blood.

    K. Irmady, C. Hale, J. Fak, R. Qadri, T. Carroll, S. Przedborski, R. Darnell, S. Simelane (NEW YORK, USA)

    Objective: To investigate the molecular correlates of clinical heterogeneity in Parkinson’s disease (PD) in the striatum and peripheral blood. Background: The molecular basis for clinical…
  • « Previous Page
  • 1
  • …
  • 146
  • 147
  • 148
  • 149
  • 150
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley